0001214659-24-009521.txt : 20240517 0001214659-24-009521.hdr.sgml : 20240517 20240517163035 ACCESSION NUMBER: 0001214659-24-009521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hernday Natasha CENTRAL INDEX KEY: 0001780547 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39801 FILM NUMBER: 24960272 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XOMA Corp CENTRAL INDEX KEY: 0000791908 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522154066 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 POWELL STREET STREET 2: SUITE 310 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-204-7239 MAIL ADDRESS: STREET 1: 2200 POWELL STREET STREET 2: SUITE 310 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: XOMA LTD /DE/ DATE OF NAME CHANGE: 19990107 FORMER COMPANY: FORMER CONFORMED NAME: XOMA CORP /DE/ DATE OF NAME CHANGE: 19920703 4 1 marketforms-65902.xml PRIMARY DOCUMENT X0508 4 2024-05-15 0000791908 XOMA Corp XOMA 0001780547 Hernday Natasha C/O XOMA CORPORATIONS 2200 POWELL STREET, SUITE 310 EMERYVILLE CA 94608 true false false false 0 Common Stock 2024-05-15 4 A false 3035 0 A 3035 D Non-Qualified Share Option (right to buy) 24.71 2024-05-15 4 A false 4881 0 A 2034-05-15 Common Stock 4881 4881 D Consists of 3,035 restricted stock units ("RSUs"). Each RSU represents the right to receive, at settlement, one share of common stock of the Company and will vest on the first anniversary of the grant date, subject to the reporting person's continued service to the Company through such vesting date. The shares subject to this option shall vest and become exercisable in equal monthly installments over the 12-month period following the date of grant (May 15, 2024), provided that the final installment will occur on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the reporting person's continued service to the Company through each vesting date. /s/ Thomas Burns, Attorney-in-Fact for Natasha Hernday 2024-05-17